DB Power and LPA announce strategic partnership to globally expand solutions for issuers of structured retail products

Real Time Search
CES A80 :
CES HKMI :
CES 120 :
Total Turn.

00950 LEE'S PHARM

Trading Add to Porfolio
Index Constituent : None
Major Shareholders Huby Technology Limited (19.36%)
Cavazza Paolo & Associates (13.01%)
GL Capital Management GP Limited (12.93%)
Li Xiaoyi (9.89%)
Gortune Investment Co. Limited (5.28%)
Huang Zuie-chin (5.09%)		 Sector Health Care & Biotechnology
Web Site http://www.leespharm.com Tel (852) 2314-1282
Email info@leespharm.com Fax N/A
Related Equities N/A
Principal Activities The principal activities are the development, manufacturing and sales of pharmaceutical products.

Consolidated List of Substantial Shareholders

Name Number of Shares Interested % of Issued Share Capital (%) Date of Last Notice Filed (Y/M/D)
李燁妮 121,322,625(L)  20.49(L)  25/01/2019
李小芳 119,902,000(L)  20.26(L)  29/05/2018
呂淑冰 61,205,708(L)  10.34(L)  29/10/2018
李小羿 61,205,708(L)  10.34(L)  29/10/2018
GSR Capital Joy Corporation 37,339,935(L)  6.31(L)  28/05/2018
Last Update : 2019-02-28
Note : (L) - Long Position (S) - Short Position (P) - Lending Pool

Complete List of Directors

Director's Name Number of Shares Interested % of issued share capital (%) Date of Last Notice Filed (Y/M/D)
李小羿 61,205,708(L)  10.34(L)  29/10/2018
Last Update : 2019-02-28
Note : (L) - Long Position (S) - Short Position (P) - Lending Pool
Back to Top